This market research study involves the extensive
use of secondary sources, directories, and databases to identify and collect
information useful for this technical, market-oriented, and financial study of
the global single-use bioprocessing market. In-depth interviews
were conducted with various primary respondents, including key industry
participants, subject-matter experts (SMEs), C-level executives of key market
players, and industry consultants, to obtain and verify critical qualitative
and quantitative information and assess market prospects.
Revenue
Growth Analysis:
[369 Pages Report] The global single-use bioprocessing market is expected to
reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of
20.5%.
Download
PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297
Key Factors Driving Market Growth:
Factors such as the increasing
demand for biopharmaceuticals & energy efficiency; the need to reduce water
wastage, equipment floor space requirement, and the risk of cross-contamination
are the key factors driving the growth of the single use bioprocessing market.
However, extractability and leachability issues regarding disposable components
and environmental & economic concerns are the major factors restraining
market growth.
Many biopharmaceutical companies have been rapidly developing vaccines in
response to the various diseases. If these development programs pass the trial
phases, the clinical and commercial manufacturing platforms will be largely
supported by single-use equipment and systems. Single-use systems are flexible
and can quickly be put in place at a lower cost than traditional
stainless-steel equipment, which has significant investments and no guarantee
of longevity for the future.
Growing Demand for Biopharmaceuticals Key Factors Driving Single-Use Bioprocessing Market:
With a growth in
the senior population across major markets, the demand for biopharmaceuticals
is expected to increase as the elderly are more prone to chronic conditions
& diseases. To cater to the growing demand for biopharmaceuticals,
companies are increasingly preferring single-use bioprocessing systems as they
increase process efficiency and decrease the costs associated with complicated
steps like cleaning, sterilization, and maintenance of steel-based bioreactor
systems.
Single-use bioprocessing technology is used in a broad range of
biopharmaceutical applications, including filtration, mixing, purification,
upstream expression, storage, and separation. Hence, the increasing demand for
biopharmaceuticals is majorly contributing to the growth of the single use
bioprocessing market.
The Single-use Media Bags and Containers
segment to dominate the Single-Use Bioprocessing Market:
Based on product, the single use bioprocessing market is categorized into
single-use media bags and containers, single-use assemblies, single-use
bioreactors, disposable mixers, and other products.
The other products segment includes single-use vessels, tubing, connectors. In
2020, the single-use media bags and containers segment accounted for the
largest share of the global single-use bioprocessing market by product. The
expanded application of single-use bags across biomanufacturing processes
drives the market for single-use media bags. Single-use bioprocessing systems
offer benefits such as lower capital investment, lower operating expenses, and
lower environmental footprint, thus driving the growing adoption of these
systems in biopharmaceutical applications.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297
North America the Largest Regional Market for Single Use Bioprocessing:
The single-use bioprocessing market is divided
into five major regions—North America, Europe, Asia Pacific, Latin America
(LATAM), and the Middle East and Africa (MEA). North America accounted for the
largest share of this market, followed by Europe in 2020. The increasing demand
for biopharmaceuticals is a major factor driving the single use bioprocessing
market in North America. The demand for biopharmaceuticals is rising owing to
the growing senior population. The rising demand for biopharmaceuticals and
advantages of single-use bioprocessing (such as high energy efficiency, low
water usage, less floor space requirement, reduced installation cost, decreased
risk of product cross-contamination, and fast implementation) drive the
adoption of the market.
Key Players in Single-Use Bioprocessing Market:
Key players in the single use
bioprocessing market include Sartorius Stedim Biotech S.A. (France), Danaher
Corporation (US), Thermo Fisher Scientific Inc. (US), and Merck KGaA (Germany).